Metraipolis › archive › dc_251114ef1986
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry — Europe PMC PMID:42283727
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42283727
- DOI
- 10.1007/s00415-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T12:49:37.223Z
- SHA-256 of the archived text
e7802cedf469ce5c4d8a69b3d8215703f39cbdc413e717ed8807ae94fa55113f- Stable URL of this page
https://metraipolis.com/documento/dc_251114ef1986
How to cite
The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry — Europe PMC PMID:42283727 — Europe PMC (en), https://europepmc.org/article/MED/42283727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_251114ef1986 (Metraipolis archive dc_251114ef1986, sha256 e7802cedf469ce5c4d8a69b3d8215703f39cbdc413e717ed8807ae94fa55113f)
BibTeX
@misc{dc251114ef1986,
title = {The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry — Europe PMC PMID:42283727},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42283727},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_251114ef1986; sha256 e7802cedf469ce5c4d8a69b3d8215703f39cbdc413e717ed8807ae94fa55113f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42283727. Agents can read the archived copy with the MCP tool read_document.